NIAID-sponsored trial of experimental Chikungunya vaccine begins
(NIH/National Institute of Allergy and Infectious Diseases) A clinical trial of an experimental vaccine to prevent infection with chikungunya virus is now enrolling healthy adult volunteers at sites in the United States.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
More News: Allergy | Allergy & Immunology | Chikungunya | Clinical Trials | Infectious Diseases | Vaccines